Related references
Note: Only part of the references are listed.Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
Magdalena Misiak-Galazka et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Interventions for chronic palmoplantar pustulosis
Grace Obeid et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis
Y. Xiaoling et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2019)
Clinical and genetic differences between pustular psoriasis subtypes
Sophie Twelves et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx
Kana Masuda-Kuroki et al.
JOURNAL OF DERMATOLOGY (2019)
The efficacy and safety of targeted narrowband UVB therapy: a retrospective cohort study
Kubra Esen Salman et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2019)
Palmoplantar Pustulosis and Allergies: A Systematic Review
Alexandra M. G. Brunasso Vernetti et al.
DERMATOLOGY PRACTICAL & CONCEPTUAL (2019)
IL-36 cytokines in autoimmunity and inflammatory disease
Liping Ding et al.
ONCOTARGET (2018)
The genetic basis for most patients with pustular skin disease remains elusive
R. Mossner et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Increased levels of lipocalin 2 in palmoplantar pustular psoriasis
Kerstin Wolk et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients
Miki Takahara et al.
JOURNAL OF DERMATOLOGY (2018)
Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis A Randomized Clinical Trial
Tadashi Terui et al.
JAMA DERMATOLOGY (2018)
A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
Victoria Cornelius et al.
TRIALS (2018)
The microbiome of the sterile pustules in palmoplantar pustulosis
Kana Masuda-Kuroki et al.
EXPERIMENTAL DERMATOLOGY (2018)
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Heng Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis
Tiago Torres et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
Andrew Johnston et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Retrospective analysis of the clinical response of palmoplantar pustulosis after dental infection control and dental metal removal
Michiyoshi Kouno et al.
JOURNAL OF DERMATOLOGY (2017)
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
Andrew Blauvelt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Quality of life and comorbidities in palmoplantar pustulosis - a cross-sectional study on 102 patients
H. Trattner et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
European consensus statement on phenotypes of pustular psoriasis
A. A. Navarini et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study
Li-na Su et al.
LASERS IN MEDICAL SCIENCE (2017)
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
Rajkumar Ganesan et al.
MABS (2017)
An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target
Satveer K. Mahil et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Alitretinoin therapy for palmoplantar pustulosis
A. M. G. Brunasso et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
Ting-Shun Wang et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)
Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial
Yoshinori Umezawa et al.
JOURNAL OF DERMATOLOGY (2016)
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects
Ines Raposo et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2016)
Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study
K. Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients
Rotraut Moessner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database
Kiyoshi Kubota et al.
BMJ OPEN (2015)
Acute Generalized Exanthematous Pustulosis Caused by Dihydrocodeine Phosphate in a Patient With Psoriasis Vulgaris and a Heterozygous IL36RN Mutation
Noriaki Nakai et al.
JAMA DERMATOLOGY (2015)
Palmoplantar pustulosis secondary to rituximab: a case report and literature review
Z. C. Venables et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2015)
Palmoplantar pustulosis - a retrospective review of comorbid conditions
G. Becher et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Pustular Bacterid: Look at the Throat for Prevention over Treatment
Fariba Iraji et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2015)
Dramatic exacerbation of palmoplantar pustulosis following strongly positive nickel patch testing
Taisuke Ito et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis
Trine Bertelsen et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
Andrew L. Croxford et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial
R. Bissonnette et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion
M. Sevrain et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Resistant Palmoplantar Lesions in Patients of Psoriasis: Evaluation of the Causes and Comparison of the Frequency of Delayed-Type Hypersensitivity in Patients without Palm and Sole Lesions
Nawaf Al-Mutairi et al.
MEDICAL PRINCIPLES AND PRACTICE (2014)
Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
Masamoto Murakami et al.
PLOS ONE (2014)
Clinical Management of Paradoxical Psoriasiform Reactions During TNF-α Therapy
R. Navarro et al.
ACTAS DERMO-SIFILIOGRAFICAS (2014)
Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis
C. Morales-Munera et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study
A. M. G. Brunasso et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis
Shiu-Chung Au et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2013)
Pustulotic arthro-osteitis associated with palmoplantar pustulosis
Toshiyuki Yamamoto
JOURNAL OF DERMATOLOGY (2013)
The Majority of Generalized Pustular Psoriasis without Psoriasis Vulgaris Is Caused by Deficiency of Interleukin-36 Receptor Antagonist
Kazumitsu Sugiura et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Utility of epithelial membrane antigen immunostaining in the differentiation between palmoplantar pustulosis and pompholyx
S. Y. Yoon et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Histological differentiation between palmoplantar pustulosis and pompholyx
S. Y. Yoon et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
A comparison of inflammatory mediator expression between palmoplantar pustulosis and pompholyx
D. Y. Kim et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
Rocio Prieto-Perez et al.
AUTOIMMUNE DISEASES (2013)
Treatment of palmoplantar pustulosis with ustekinumab - the importance of interfering with the IL23/Th17 pathway
Teresa Pinto-Almeida et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2013)
Calcium homeostasis and body composition in patients with palmoplantar pustulosis: a case-control study
E. Hagforsen et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk
Luigi Tortola et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Plantar pustulosis during rituximab therapy for rheumatoid arthritis
Alexandra Maria Giovanna Brunasso et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: The Mayo Clinic experience, 1998 to 2010
Eugenia Shmidt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Hand Eczema
Pieter-Jan Coenraads
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Interleukin-6: from an inflammatory marker to a target for inflammatory diseases
Mercedes Rincon
TRENDS IN IMMUNOLOGY (2012)
Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications
Wen G. Jiang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum
Masamoto Murakami et al.
EXPERIMENTAL DERMATOLOGY (2011)
ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis
Konstantinos Douroudis et al.
HUMAN IMMUNOLOGY (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Pustulosis palmoplantaris is a disease distinct from psoriasis
Anne C. de Waal et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2011)
Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
Yijun Carrier et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study
R. Bissonnette et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Slaheddine Marrakchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Normal and PPP-affected palmoplantar sweat gland express neuroendocrine markers chromogranins and synaptophysin differently
Eva Hagforsen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2010)
Ustekinumab in the treatment of palmoplantar pustulosis
S. Gerdes et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis
E. Hagforsen et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Acrosyringium Is the Main Site of the Vesicle/Pustule Formation in Palmoplantar Pustulosis
Masamoto Murakami et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Can we really separate palmoplantar pustulosis from psoriasis?
A. M. G. Brunasso et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab
M. T. Bordel-Gomez et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Extra-palmoplantar lesions associated with palmoplantar pustulosis
T. Yamamoto
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients
E. Adisen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Different Applications of Monochromatic Excimer Light in Skin Diseases
Steven Paul Nistico et al.
PHOTOMEDICINE AND LASER SURGERY (2009)
Complete remission of palmoplantar psoriasis through Helicobacter pylori eradication:: a case report
A. Martin Hubner et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)
IL-8 as antibody therapeutic target in inflammatory diseases: Reduction of clinical activity in palmoplantar pustulosis
Lone Skov et al.
JOURNAL OF IMMUNOLOGY (2008)
Palmoplantar pustulosis and gluten sensitivity:: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet
G. Michaelsson et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis
K. Kingo et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Expression of cutaneous lymphocyte-associated antigen (CLA) in tonsillar T-cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris (PPP)
H Nozawa et al.
CLINICAL IMMUNOLOGY (2005)
Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses
B Engin et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2005)
Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: A case-control study
E Hagforsen et al.
ACTA DERMATO-VENEREOLOGICA (2005)
Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris
R Mossner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: Implications for clinical practice
AA Pettey et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
IL-6, monocyte infiltration and parenchymal cells
E Bartoccioni et al.
TRENDS IN IMMUNOLOGY (2003)
Palmoplantar pustulosis:: a clinicoepidemiological study.: The relationship between tobacco use and thyroid function
R Giménez-García et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis
K Asumalahti et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Palmoplantar pustulosis:: an autoimmune disease precipitated by smoking?
E Hagforsen et al.
ACTA DERMATO-VENEREOLOGICA (2002)
The role of psychological factors in palmoplantar pustulosis
M Sáez-Rodríguez et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2002)
Palmoplantar lesions in psoriasis: A study of 3065 patients
B Kumar et al.
ACTA DERMATO-VENEREOLOGICA (2002)
Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis
E Hagforsen et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Acitretin therapy for palmoplantar pustulosis combined with UVA and topical 8-MOP
K Ettler et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2001)
Share Paper
